Weight loss drug 'Ozempic' approved for use in India: What we need to know about its health benefits and risks
India has officially approved Ozempic (semaglutide), a once-a-week injection for adults with type 2 diabetes, which also aids in weight loss. This GLP-1 receptor analogue helps control blood sugar, offers cardiovascular protection, and supports healthier eating habits. While promising for India's rising diabetes rates, users should be aware of potential side effects.
India has officially approved Ozempic (semaglutide), a once-a-week injection for adults with type 2 diabetes, which also aids in weight loss. This GLP-1 receptor analogue helps control blood sugar, offers cardiovascular protection, and supports healthier eating habits. While promising for India's rising diabetes rates, users should be aware of potential side effects.
